[Treatable immune-mediated neuropathies].
We discuss current approaches in the treatment of immune mediated neuropathies and review recent progress in management. Intensive evaluation has led to improved diagnosis of the cause of neuropathies. Because immunosuppressive drugs are potentially hazardous, strict guidelines for their clinical use, including clinical immunological, neurophysiological and histological investigations, should be followed.
Steck
A J
AJ
Neurologische Universitätsklinik, Kantonsspital Basel.
Früh
J
J
D001327:Autoimmune Diseases / Q000150:complications; D006801:Humans; D007154:Immune System Diseases / Q000150:complications*; D007075:Immunoglobulin M; D009422:Nervous System Diseases / Q000209:etiology* / Q000276:immunology; D010257:Paraneoplastic Syndromes / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000209:etiology* / Q000276:immunology; D011115:Polyneuropathies / Q000276:immunology; D011129:Polyradiculoneuropathy / Q000276:immunology
D007075:Immunoglobulin M